Target intelligence / Profile preview

Severe acute respiratory syndrome coronavirus 2 viral epitopes (SARS-CoV-2 epitopes) (SARS-CoV-2 epitopes)

Target
SARS-CoV-2 epitopes
Molecular classification
Viral protein, Antigen
01

Overview

SARS-CoV-2 viral epitopes are specific molecular regions of the Severe Acute Respiratory Syndrome Coronavirus 2 that are recognized by the host immune system, specifically by antibodies and T-cell receptors (Grifoni et al., 2020, Cell Host & Microbe). The most prominent epitopes are located on the Spike (S) protein, particularly within the receptor-binding domain (RBD), which is critical for the virus's ability to bind to the human Angiotensin-Converting Enzyme 2 (ACE2) receptor and enter host cells (Hoffmann et al., 2020, Cell). Other significant epitopes are found on the Nucleocapsid (N), Membrane (M), and Envelope (E) proteins, which play roles in viral assembly and structural integrity (UniProt, 2021). These epitopes are the fundamental components used in the design of mRNA, viral vector, and protein subunit vaccines, such as BNT162b2 and mRNA-1273 (Polack et al., 2020, NEJM; Baden et al., 2021, NEJM). Therapeutic strategies focus on blocking these epitopes with monoclonal antibodies like Sotrovimab or Casirivimab to prevent viral entry or mark the virus for destruction (Gottlieb et al., 2021, JAMA). However, the rapid evolution of the virus leads to mutations in these epitope regions, potentially resulting in immune escape and reduced efficacy of existing medical countermeasures (Harvey et al., 2021, Nature Reviews Microbiology). Continuous monitoring of epitope changes is essential for the development of next-generation vaccines and therapeutics (WHO, 2023).

Other names
SARS-CoV-2 antigensCOVID-19 epitopesSpike protein epitopesNucleocapsid protein epitopesSARS-CoV-2 T-cell epitopesSARS-CoV-2 B-cell epitopes
02

Mechanism of action

Neutralization of viral entry by blocking the receptor-binding domain (RBD) of the Spike protein, thereby preventing interaction with the host ACE2 receptor, and the induction of adaptive immune responses including neutralizing antibodies and T-cell activation (Hoffmann et al., 2020, Cell; Grifoni et al., 2020, Cell Host & Microbe).

03

Biological functions

Viral entryImmune recognitionViral assemblyHost cell attachment
04

Disease associations

InfectionCOVID-19
05

Safety considerations

Immune escape due to viral mutationAntibody-dependent enhancement (ADE)Vaccine-induced immune thrombotic thrombocytopenia (VITT)Myocarditis
06

Interacting drugs

Tozinameran

8 more in the full profile.

07

Biomarkers

Anti-Spike IgG antibody titerNeutralizing antibody levelsInterferon-gamma productionT-cell activation markers

Beyond the preview

Go deeper on Severe acute respiratory syndrome coronavirus 2 viral epitopes (SARS-CoV-2 epitopes) (SARS-CoV-2 epitopes).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Severe acute respiratory syndrome coronavirus 2 viral epitopes (SARS-CoV-2 epitopes) (SARS-CoV-2 epitopes).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call